# OZANIMOD
> **ANDA219236** · Abbreviated New Drug Application (Generic) · Sponsor: SYNTHON BV · Approved 2025-07-22
## Drug
- **FDA Application Number:** ANDA219236
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OZANIMOD
- **Generic name:** Ozanimod
- **Active ingredients:** OZANIMOD
- **Dosage form:** CAPSULE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SYNTHON BV
- **First approval:** 2025-07-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219236)
---
*AI Analytics · CC0 1.0*